Outlook Therapeutics Inc. Stock Performance
as on June 23, 2026 at 3:08 am IST
Day's Low
Day's High
$1.52$1.70
7.32%
Downside
3.66%
Upside
52 Week's Low
52 Week's High
$0.16$3.3990.18%
Downside
106.71%
Upside
Outlook Therapeutics Inc. share price movements today
- Previous Close
- $1.58
- Open
- $1.53
- Volume
- 5.7M
- Day's Low - High
- $1.52 - $1.70
- 52 Week Low - High
- $0.16 - $3.39
Outlook Therapeutics Inc. Historical Returns
- 1 Month Return
- + 409.84 %
- 3 Month Return
- + 350.01 %
- 1 Year Return
- -7.33 %
- 3 Year Return
- -95.43 %
- 5 Year Return
- -96.62 %
Outlook Therapeutics Inc. Stock Fundamentals & Key Indicators
Check Outlook Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$191.0M
EPS (TTM)
-0.51
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-60.5M
Revenue (TTM)
333.1K
Profit Margin
0.00%
Return On Equity TTM
-3.65%
Outlook Therapeutics Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Outlook Therapeutics Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $191.0M | -96.62% | NA | 0.00% | NA | |
| BUY | $37.1B | 60.79% | 69.87 | 12.55% | NA | |
| BUY | $114.6B | 139.12% | 26.8 | 35.51% | NA | |
| BUY | $63.9B | 14.22% | 14.88 | 29.65% | 0.59% |
Stock Returns calculator for Outlook Therapeutics Inc. Stock including INR - Dollar returns
The Outlook Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Outlook Therapeutics Inc. investment value today
Current value as on today
₹1,04,879
Returns
₹4,879
(+4.88%)
Returns from Outlook Therapeutics Inc. Stock
Dollar Impact
₹8,973 (+8.97%)
Analyst Recommendation on Outlook Therapeutics Inc. Stock
Based on 13 analysts
92.31%
Buy
7.69%
Hold
0.00%
Sell
Based on 13 analysts, 92.31% of analysts recommend a 'BUY' rating for Outlook Therapeutics Inc.. Average target price of $5.5
Outlook Therapeutics Inc. Share Price Target
Get share price movements and forecasts by analysts on Outlook Therapeutics Inc..
What analysts predicted
70.18%UPSIDE
Target Price
$5.5
Current Price
$1.64
Analyzed by
13 Analysts
Target
$5.50
Outlook Therapeutics Inc. target price $5.5, a slight upside of 70.18% compared to current price of $1.64. According to 13 analysts rating.
Indian Investors' Interest in Outlook Therapeutics Inc. Stock
Investment in Outlook Therapeutics Inc. Shares on INDmoney has grown by 1022.03% in the last 30 days, indicating increased investment activity.
Time period: to
Change:1022.03% versus previous 30 day period
Search interest for Outlook Therapeutics Inc. Stock has increased by 1744% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:1744% versus previous 30 day period
Outlook Therapeutics Inc. Quarterly Profit & Loss
All numbers in Millions USD
Outlook Therapeutics Inc. Annual Profit & Loss
All numbers in Millions USD
Outlook Therapeutics Inc. Quarterly Cash Flow
All numbers in Millions USD
Outlook Therapeutics Inc. Annual Cash Flow
All numbers in Millions USD
Outlook Therapeutics Inc. News & Key Events
Today's Timeline - 02 January
Fri, 06:48 PM
-Outlook Therapeutics stock hits 52-week low after FDA rejects Lytenava filing for wet AMD due to insufficient evidence.
Insights on Outlook Therapeutics Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 7 days, OTLK stock has moved up by 36.2%
NO EFFECTAgainst Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 19.7% return, outperforming this stock by 27.0%
- NO EFFECT
Against Peers
In the last 3 years, Outlook Therapeutics, Inc. Common Stock has experienced a drawdown of -95.4%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 73.6%
About Outlook Therapeutics Inc.
| Organisation | Outlook Therapeutics Inc. |
| Headquarters | 111 S. Wood Avenue, Iselin, NJ, United States, 08830 |
| Industry | Biotechnology |
| CEO | Mr. Robert Charles Jahr |
| E-voting on shares | Click here to vote |
Key Management of Outlook Therapeutics Inc.
Name | Title |
|---|---|
Mr. Joel Prieve | Senior Vice President of Licensing and M&A |
Dr. Surendra Sharma M.D. | Senior Vice President of Medical Affairs |
Dr. Jennifer M. Kissner Ph.D. | Senior Vice President of Clinical Development & Regulatory Affairs |
Mr. Jedd Comiskey | Senior VP - Head of Europe |
Mr. Robert Charles Jahr | President, CEO & Director |
Mr. Lawrence A. Kenyon CPA | EVP, CFO, Treasurer, Secretary & Director |
FAQs
What is Outlook Therapeutics Inc. share price today?
Outlook Therapeutics Inc. share price today is $1.64 as on . Outlook Therapeutics Inc. share today touched a day high of $1.7 and a low of $1.52.
What is the 52 week high and 52 week low for Outlook Therapeutics Inc. share?
Outlook Therapeutics Inc. share touched a 52 week high of $3.39 on and a 52 week low of $0.16 on . Outlook Therapeutics Inc. stock price today i.e. is trending at $1.64,which is 51.62% down from its 52 week high and 918.00% up from its 52 week low.
What is Outlook Therapeutics Inc.'s market capitalisation today?
Outlook Therapeutics Inc. market capitalisation is $0.00T as on .
How to invest in Outlook Therapeutics Inc. Stock (OTLK) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Outlook Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Outlook Therapeutics Inc. Shares that will get you 0.9146 shares as per Outlook Therapeutics Inc. share price of $1.64 per share as on June 22, 2026 at 9:38 pm IST.
What is the minimum amount required to buy Outlook Therapeutics Inc. Stock (OTLK) from India?
Indian investors can start investing in Outlook Therapeutics Inc. (OTLK) shares with as little as ₹94.68 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.80 in Outlook Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Outlook Therapeutics Inc. share’s latest price of $1.64 as on June 22, 2026 at 9:38 pm IST, you will get 6.0976 shares of Outlook Therapeutics Inc.. Learn more about
fractional shares .
What are the returns that Outlook Therapeutics Inc. has given to Indian investors in the last 5 years?
Outlook Therapeutics Inc. stock has given -96.62% share price returns and 26.88% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?